Medicine and Dentistry
Bisindolylmaleimide
100%
Drug
62%
Chemotherapeutic Agent
62%
Chronic Myelogenous Leukemia
50%
Cells
37%
Leukemia
25%
Cell Cycle Arrest
25%
Topoisomerase
25%
Oncogene Addiction
25%
Side Effect
25%
Diseases
12%
Protein P53
12%
Combination Therapy
12%
Programmed Cell Death
12%
Cytotoxicity
12%
Antiinfective Agent
12%
Drug Resistance
12%
DNA Damage
12%
Lifespan
12%
Stress
12%
Development
12%
Cancer Model
12%
Therapeutic Procedure
12%
Pharmacology, Toxicology and Pharmaceutical Science
Bisindolylmaleimide
100%
Drug
62%
Chronic Myeloid Leukemia
50%
Leukemia
25%
DNA Topoisomerase
25%
Oncogene Addiction
25%
Diseases
12%
Cytotoxicity
12%
Antiinfective Agent
12%
DNA
12%
Protein P53
12%
Mouse Model
12%
Drug Resistance
12%
Mouse
12%
Cancer Model
12%
Biochemistry, Genetics and Molecular Biology
Bisindolylmaleimide
100%
Myeloid
50%
Electric Potential
25%
Cell Cycle Arrest
25%
P53
12%
Lifespan
12%
Cytotoxicity
12%
Development
12%
Mouse Model
12%
DNA Damage
12%
Topoisomerase
12%
Cell Death
12%
Small Molecule
12%
Stress
12%
Mouse
12%
DNA Topoisomerase
12%
Drug Resistance
12%
Experiment
12%
Dose
12%
Neuroscience
Bisindolylmaleimide
100%
Myeloid
50%
Topoisomerase
25%
Cell Cycle Arrest
25%
Addiction
25%
DNA
12%
P53
12%
DNA Damage
12%
Cytotoxicity
12%
Drug Resistance
12%
Material Science
Cell
62%
DNA
37%
Cell Death
12%
Agent
12%